Moclobemide, a MAO-A inhibitor, is an antidepressant that has no tyramine effect and is comparable to tricyclic amines and serotonin reuptake inhibitors and has been studied in elderly patients with cognitive decline and depression [12]. Here, MAOA is linked to depressive symptom measurement.